Literature DB >> 2328928

NMR analysis of low-density lipoprotein oxidatively-modified in vitro.

L Barenghi1, S Bradamante, G A Giudici, C Vergani.   

Abstract

Human plasma low density lipoprotein has been oxidized at different stages in vitro and analysed by 1H, 13C, and 31P NMR spectroscopy and by biochemical methods. Information was obtained on: a) structure mobilities of lipids and on lipid-protein interactions; b) conjugated and oxo-dienes; c) polyunsaturated/monounsaturated fatty acid chains; d) lysophosphatidylcholine production. The results show that the NMR approach is particularly useful for the assessment of structural modification in oxidized LDL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328928     DOI: 10.3109/10715769009087991

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  4 in total

1.  Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition.

Authors:  D F Meyer; A S Nealis; C H Macphee; P H Groot; K E Suckling; K R Bruckdorfer; S J Perkins
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

2.  Aldehydes from metal ion- and lipoxygenase-induced lipid peroxidation: detection by 1H-n.m.r. spectroscopy.

Authors:  J K Lodge; S U Patel; P J Sadler
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

3.  Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.

Authors:  D F Meyer; M O Mayans; P H Groot; K E Suckling; K R Bruckdorfer; S J Perkins
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

4.  NMR spectroscopy of macrophages loaded with native, oxidized or enzymatically degraded lipoproteins.

Authors:  Paul Ramm Sander; Markus Peer; Margot Grandl; Ulrich Bogdahn; Gerd Schmitz; Hans Robert Kalbitzer
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.